Oxford University Press (OUP), Nephrology Dialysis Transplantation, 10(27), p. 3908-3914
DOI: 10.1093/ndt/gfr661
Full text: Download
The staggering cardiovascular risk of kidney failure and the disappointing results of very recent and older trials are a sounding board that nephrologists should multiply efforts at identifying modifiable risk factors, to improve the dim health perspectives of dialysis patients. Moving PH from the limbo category (WHO V) where it stands now, to categories of known aetiology, may perhaps be a significant step towards this tantalizing goal.